malondialdehyde has been researched along with sodium cyanide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boffi, FM; Inanami, O; Kuwabara, M; Matsuki, N; Ono, K; Takanohashi, A | 1 |
| Kiang, JG; Krishnan, S; Li, Y; Lu, X | 1 |
2 other study(ies) available for malondialdehyde and sodium cyanide
| Article | Year |
|---|---|
Hydroxyl radical generation and lipid peroxidation in C2C12 myotube treated with iodoacetate and cyanide.
Topics: Animals; Cell Line; Cyclic N-Oxides; Deferoxamine; Drug Resistance; Electron Spin Resonance Spectroscopy; Hydroxyl Radical; Iodoacetates; Iron Chelating Agents; Kinetics; L-Lactate Dehydrogenase; Lipid Peroxidation; Malondialdehyde; Mice; Muscle, Skeletal; Sodium Cyanide; Spin Labels; Superoxide Dismutase | 1999 |
Inhibition of inducible nitric-oxide synthase protects human T cells from hypoxia-induced apoptosis.
Topics: Apoptosis; Caspase 3; Dose-Response Relationship, Drug; fas Receptor; Gene Expression Regulation, Enzymologic; Humans; Hypoxia; Jurkat Cells; Leukotriene B4; Lipid Peroxidation; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Sodium Cyanide; Statistics as Topic; T-Lymphocytes; Time Factors | 2008 |